Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-24-284233
Filing Date
2024-12-23
Accepted
2024-12-23 16:39:06
Documents
98

Document Format Files

Seq Description Document Type Size
1 S-1 d918358ds1.htm   iXBRL S-1 4488910
2 EX-5.1 d918358dex51.htm EX-5.1 8968
3 EX-23.1 d918358dex231.htm EX-23.1 1631
9 EX-FILING FEES d918358dexfilingfees.htm EX-FILING FEES 16662
10 GRAPHIC g918358dsp1.jpg GRAPHIC 3047
11 GRAPHIC g918358g01m18.jpg GRAPHIC 123914
12 GRAPHIC g918358g02k18.jpg GRAPHIC 132588
13 GRAPHIC g918358g11a01.jpg GRAPHIC 36739
14 GRAPHIC g918358g19g19.jpg GRAPHIC 128453
15 GRAPHIC g918358g21g21.jpg GRAPHIC 97359
  Complete submission text file 0001193125-24-284233.txt   22606553

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cdtx-20240930.xsd EX-101.SCH 68881
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdtx-20240930_cal.xml EX-101.CAL 74527
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdtx-20240930_def.xml EX-101.DEF 517875
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdtx-20240930_lab.xml EX-101.LAB 623513
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdtx-20240930_pre.xml EX-101.PRE 677549
101 EXTRACTED XBRL INSTANCE DOCUMENT d918358ds1_htm.xml XML 5861191
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284022 | Film No.: 241574247
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)